References
- Middleton AM, Reynolds J, Cable S, et al. Are non-animal systemic safety assessments protective? A toolbox and workflow. Toxicol Sci. 2022;189(1):124–147. doi: 10.1093/toxsci/kfac068
- Pallocca G, Moné MJ, Kamp H, et al. Next-generation risk assessment of chemicals - rolling out a human-centric testing strategy to drive 3R implementation: the RISK-HUNT3R project perspective. ALTEX. 2022;39(3):419–426. doi: 10.14573/altex.2204051
- Currie RA, Abbott J, Dreier DA, et al. Developing prototypes of a modernized approach to assess crop protection chemical safety. ALTEX. 2024;41(1):119–130. doi: 10.14573/altex.2307181
- Bajard L, Adamovsky O, Audouze K, et al. Application of AOPs to assist regulatory assessment of chemical risks - case studies, needs and recommendations. Environ Res. 2023;217:114650. doi: 10.1016/j.envres.2022.114650
- Botham P, Cronin MTD, Currie R, et al. Analysis of health concerns not addressed by REACH for low tonnage chemicals and opportunities for new approach methodology. Arch Toxicol. 2023;97(12):3075–3083. doi: 10.1007/s00204-023-03601-5
- Najjar A, Punt A, Wambaugh J, et al. Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment. Arch Toxicol. 2022;96(12):3407–3419. doi: 10.1007/s00204-022-03356-5
- Hilton GM, Bhuller Y, Doe JE, et al. A new paradigm for regulatory sciences. Regul Toxicol Pharmacol. 2023;145:105524. doi: 10.1016/j.yrtph.2023.105524
- Schmeisser S, Miccoli A, von Bergen M, et al. New approach methodologies in human regulatory toxicology - not if, but how and when! Environ Int. 2023;178:108082. doi: 10.1016/j.envint.2023.108082
- European Chemicals Agency (ECHA). Report on alternatives to animal testing. 2023. Available from: https://echa.europa.eu/specific-reports-reach
- van der Zalm AJ, Barroso J, Browne P, et al. A framework for establishing scientific confidence in new approach methodologies. Arch Toxicol. 2022;96(11):2865–2879. doi: 10.1007/s00204-022-03365-4
- Alexander-White C, Bury D, Cronin M, et al. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment. Regul Toxicol Pharmacol. 2022;129:105094. doi: 10.1016/j.yrtph.2021.105094
- Paul Friedman K, Gagne M, Loo LH, et al. Utility of in vitro bioactivity as a lower bound estimate of in vivo adverse effect levels and in risk-based prioritization. Toxicol Sci. 2020;173(1):202–225. doi: 10.1093/toxsci/kfz201
- van Tongeren TCA, Wang S, Carmichael PL, et al. Next generation risk assessment of human exposure to estrogens using safe comparator compound values based on in vitro bioactivity assays. Arch Toxicol. 2023;97(6):1547–1575. doi: 10.1007/s00204-023-03480-w
- Maertens A, Golden E, Luechtefeld TH, et al. Probabilistic risk assessment - the keystone for the future of toxicology. ALTEX. 2022;39(1):3–29. doi: 10.14573/altex.2201081
- United Nations Global Framework on Chemicals. 2023 [cited 2023 Nov 30]. Available from: https://www.unep.org/news-and-stories/statements/unep-welcomes-new-global-framework-chemicals